Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0000947871-18-000308

Director sold 1,048,067 shares at an average $11.50 ($12,053,730)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Peter A. Director 2018-03-27 Sale −1,016,084 $11.50 $11,684,966 5,133,293 I: show line 1 in the form
Thompson Peter A. Director 2018-03-29 Sale −31,983 $11.53 $368,764 5,101,310 I: show line 2 in the form
Open-market sales · 1,048,067 sh · avg $11.50 · $12,053,730
Loading xslF345X03/ss86035_4.xml…